BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23689522)

  • 1. Inflammasomes in inflammatory bowel disease pathogenesis.
    Hao LY; Liu X; Franchi L
    Curr Opin Gastroenterol; 2013 Jul; 29(4):363-9. PubMed ID: 23689522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models.
    Aguilera M; Darby T; Melgar S
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):715-30. PubMed ID: 24803013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolome and inflammasome in inflammatory bowel disease.
    Nanau RM; Neuman MG
    Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine.
    Rosenstiel P
    Curr Opin Gastroenterol; 2013 Mar; 29(2):125-32. PubMed ID: 23337934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications.
    Osawa R; Williams KL; Singh N
    J Infect; 2011 Feb; 62(2):119-29. PubMed ID: 20950647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?
    Robertson SJ; Girardin SE
    Curr Opin Gastroenterol; 2013 Jan; 29(1):15-22. PubMed ID: 23132210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.
    Levy M; Thaiss CA; Katz MN; Suez J; Elinav E
    Semin Immunopathol; 2015 Jan; 37(1):39-46. PubMed ID: 25315349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inflammasomes: platforms of innate immunity].
    Jamilloux Y; Henry T
    Med Sci (Paris); 2013 Nov; 29(11):975-84. PubMed ID: 24280500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.
    Cucchiara S; Stronati L; Aloi M
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.
    Malik A; Sharma D; Malireddi RKS; Guy CS; Chang TC; Olsen SR; Neale G; Vogel P; Kanneganti TD
    Immunity; 2018 Sep; 49(3):515-530.e5. PubMed ID: 30231985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation.
    Kurashima Y; Goto Y; Kiyono H
    Eur J Immunol; 2013 Dec; 43(12):3108-15. PubMed ID: 24414823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commensal-innate immune miscommunication in IBD pathogenesis.
    Cario E
    Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasomes.
    de Zoete MR; Palm NW; Zhu S; Flavell RA
    Cold Spring Harb Perspect Biol; 2014 Oct; 6(12):a016287. PubMed ID: 25324215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms involved in inflammasome activation.
    Bryant C; Fitzgerald KA
    Trends Cell Biol; 2009 Sep; 19(9):455-64. PubMed ID: 19716304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells: the commanders-in-chief of mucosal immune defenses.
    Niess JH; Reinecker HC
    Curr Opin Gastroenterol; 2006 Jul; 22(4):354-60. PubMed ID: 16760749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
    Cader MZ; Kaser A
    Gut; 2013 Nov; 62(11):1653-64. PubMed ID: 24104886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of bacteria by inflammasomes.
    von Moltke J; Ayres JS; Kofoed EM; Chavarría-Smith J; Vance RE
    Annu Rev Immunol; 2013; 31():73-106. PubMed ID: 23215645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
    Elson CO; Cong Y; McCracken VJ; Dimmitt RA; Lorenz RG; Weaver CT
    Immunol Rev; 2005 Aug; 206():260-76. PubMed ID: 16048554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.